- Home
- ADUS
as 03-28-2025 3:30pm EST
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.
| Founded: | 1979 | Country: | United States |
| Employees: | N/A | City: | FRISCO |
| Market Cap: | 2.0B | IPO Year: | 2009 |
| Target Price: | $134.73 | AVG Volume (30 days): | 217.2K |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 4.23 | EPS Growth: | 10.44 |
| 52 Week Low/High: | $87.88 - $136.72 | Next Earning Date: | 05-05-2025 |
| Revenue: | $1,154,599,000 | Revenue Growth: | 9.06% |
| Revenue Growth (this year): | 24.81% | Revenue Growth (next year): | 5.97% |
Stock Insider Trading Activity of Addus HomeCare Corporation (ADUS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| RAINES MONICA | ADUS | EVP/CCO and Quality Officer | Mar 3 '25 | Sell | $96.23 | 237 | $22,806.51 | 14,645 | |
| Stevenson Roberton James | ADUS | EVP & Chief HR Officer | Feb 25 '25 | Sell | $99.90 | 308 | $30,769.20 | 12,812 | |
| RAINES MONICA | ADUS | EVP/CCO and Quality Officer | Feb 25 '25 | Sell | $99.73 | 254 | $25,331.42 | 14,645 | |
| WATTENBARGER MICHAEL D. | ADUS | EVP/Chief Information Officer | Feb 25 '25 | Sell | $99.71 | 343 | $34,200.53 | 9,841 | |
| ALLISON R DIRK | ADUS | CEO and Chairman | Feb 25 '25 | Sell | $99.98 | 2,564 | $256,348.72 | 102,961 | |
| BICKHAM W BRADLEY | ADUS | President and COO | Feb 25 '25 | Sell | $99.74 | 2,444 | $243,764.56 | 51,505 | |
| GAFFNEY SEAN | ADUS | EVP / Chief Legal Officer | Feb 25 '25 | Sell | $99.84 | 479 | $47,823.36 | 18,179 | |
| TUCKER DAVID W. | ADUS | EVP / Chief Strategy Officer | Feb 25 '25 | Sell | $99.77 | 411 | $41,005.47 | 11,138 | |
| POFF BRIAN | ADUS | EVP/Chief Financial Officer | Feb 25 '25 | Sell | $99.88 | 2,304 | $230,123.52 | 32,969 | |
| BLESSING CLIFF DONALD | ADUS | EVP/Chief Development Officer | Feb 25 '25 | Sell | $99.81 | 191 | $19,063.71 | 10,579 |
Latest Addus HomeCare Corporation News
ADUS Breaking Stock News: Dive into ADUS Ticker-Specific Updates for Smart Investing
StockStory
10 hours ago
A Look Back at Senior Health, Home Health & Hospice Stocks’ Q4 Earnings: BrightSpring Health Services (NASDAQ:BTSG) Vs The Rest Of The Pack
StockStory
a day ago
3 Reasons ADUS is Risky and 1 Stock to Buy Instead
Argus Research
3 days ago
ADUS: Raising target price to $100.00
StockStory
7 days ago
Senior Health, Home Health & Hospice Stocks Q4 Earnings: Option Care Health (NASDAQ:OPCH) Best of the Bunch
Simply Wall St.
9 days ago
Here's Why Addus HomeCare (NASDAQ:ADUS) Has Caught The Eye Of Investors
Zacks
9 days ago
ADUS vs. USPH: Which Stock Is the Better Value Option?
Zacks
10 days ago
Are Investors Undervaluing Addus HomeCare (ADUS) Right Now?
MT Newswires
17 days ago
Addus HomeCare COO Bradley Bickham to Retire in 2026
Compare ADUS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ADUS Addus HomeCare Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.